Cargando…

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Purpose: Exosomes, small extracellular vesicles (EVs) derived from the endocytic compartment of their parent cells, are present in plasma of cancer patients and may serve as non-invasive biomarkers of disease outcome. Here, we asked whether tumor-derived (TEX) and/or T-cell derived exosomes can pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theodoraki, Marie-Nicole, Yerneni, Saigopalakrishna, Gooding, William E., Ohr, James, Clump, David A., Bauman, Julie E., Ferris, Robert L., Whiteside, Theresa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527269/ https://www.ncbi.nlm.nih.gov/pubmed/31143513 http://dx.doi.org/10.1080/2162402X.2019.1593805

Ejemplares similares

Plasma-derived Exosomes Reverse Epithelial-to-Mesenchymal Transition after Photodynamic Therapy of Patients with Head and Neck Cancer
por: Theodoraki, Marie-Nicole, et al.
Publicado: (2018)

Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(−) Head and Neck Cancer Cell Lines
por: Ludwig, Sonja, et al.
Publicado: (2018)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia
por: Hong, Chang-Sook, et al.
Publicado: (2017)

Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression
por: Azambuja, Juliana H., et al.
Publicado: (2020)

Molecular profiles and immunomodulatory activities of glioblastoma-derived exosomes
por: Azambuja, Juliana Hofstatter, et al.
Publicado: (2020)

Simultaneous Inhibition of Glycolysis and Oxidative Phosphorylation Triggers a Multi-Fold Increase in Secretion of Exosomes: Possible Role of 2′3′-cAMP
por: Ludwig, Nils, et al.
Publicado: (2020)

Author Correction: Simultaneous Inhibition of Glycolysis and Oxidative Phosphorylation Triggers a Multi-Fold Increase in Secretion of Exosomes: Possible Role of 2′,3′-cAMP
por: Ludwig, Nils, et al.
Publicado: (2020)

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
por: Thomas, Joel, et al.
Publicado: (2020)

Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients
por: Theodoraki, M.-N., et al.
Publicado: (2021)

Arginase-1 in Plasma-Derived Exosomes as Marker of Metastasis in Patients with Head and Neck Squamous Cell Carcinoma
por: Hofmann, Linda, et al.
Publicado: (2023)

STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV(+) status in head and neck cancer
por: Lu, Shanhong, et al.
Publicado: (2018)

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
por: Habl, Gregor, et al.
Publicado: (2010)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients
por: Li, Jing, et al.
Publicado: (2015)

Postoperative IMRT in head and neck cancer
por: Studer, Gabriela, et al.
Publicado: (2006)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2022)

Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets
por: Muller, Laurent, et al.
Publicado: (2016)

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells
por: Ming Lim, Chwee, et al.
Publicado: (2013)

Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma
por: Ludwig, Nils, et al.
Publicado: (2020)

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
por: Klinghammer, Konrad, et al.
Publicado: (2020)

CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients’ plasma as potential noninvasive biomarkers of disease activity
por: Theodoraki, Marie-Nicole, et al.
Publicado: (2020)

Circulating exosomes carrying an immunosuppressive cargo may interfere with adoptive cell therapies in leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2015)

Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
por: Srivastava, Raghvendra M, et al.
Publicado: (2015)

The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer
por: Hofmann, Linda, et al.
Publicado: (2020)

Brain-Sparing Methods for IMRT of Head and Neck Cancer
por: Dunlop, Alex, et al.
Publicado: (2015)

IMRT for head and neck cancer: reducing xerostomia and dysphagia
por: Wang, XiaoShen, et al.
Publicado: (2016)

Proteomes of exosomes from HPV(+) or HPV(-) head and neck cancer cells: differential enrichment in immunoregulatory proteins
por: Ludwig, Sonja, et al.
Publicado: (2019)

A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
por: Ferris, Robert L, et al.
Publicado: (2015)

Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study
por: Wu, Xin, et al.
Publicado: (2016)

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck
por: BAUMAN, JESSICA, et al.
Publicado: (2013)

Cell trafficking and regulation of osteoblastogenesis by extracellular vesicle associated bone morphogenetic protein 2
por: Yerneni, Saigopalakrishna S., et al.
Publicado: (2021)

TGFβ(+) small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro‐angiogenic phenotype
por: Ludwig, Nils, et al.
Publicado: (2022)

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
por: Borson, Steven, et al.
Publicado: (2022)

A Nomogram to predict parotid gland overdose in head and neck IMRT
por: Castelli, J., et al.
Publicado: (2016)

Outcome in recurrent head neck cancer treated with salvage-IMRT
por: Studer, Gabriela, et al.
Publicado: (2008)

Lhermitte's Sign Developing after IMRT for Head and Neck Cancer
por: Lim, Dong C., et al.
Publicado: (2010)

Dosimetric impact of the 160 MLC on head and neck IMRT treatments
por: Rassiah‐Szegedi, Prema, et al.
Publicado: (2014)

Evaluation of auto‐planning in IMRT and VMAT for head and neck cancer
por: Ouyang, Zi, et al.
Publicado: (2019)

Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer
por: Bollen, Heleen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtr70u4u6r59lmna7rm1k1fon3